2025-11-14T10:57:02-06:00 2024-12-31 390859910 BAKER TILLY ADVISORY GROUP LP 1570 FRUITVILLE PIKE SUITE 400 LANCASTER PA 17601 990 2024-01-01 521906152 PARENTERAL DRUG ASSOCIATION INC PARE 3016565900 4350 EAST WEST HIGHWAY 600 BETHESDA MD 20814 JENNIFER BELL CHIEF FINANCIAL OFFICER 3016565900 2025-11-14 1 1 X KERRI N BOGDA P00760402 7177404863 2025-11-11 2024 2025-03-06 01:10:19Z X GLENN WRIGHT 4350 EAST WEST HIGHWAY 600 BETHESDA MD 20814 15525483 0 X WWW.PDA.ORG X 1994 DC TO BE THE FOREMOST GLOBAL PROVIDER OF SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION AND EDUCATION FOR THE PHARMACEUTICAL AND BIOPHARMACEUTICAL COMMUNITY. 17 17 57 1891 218208 0 117767 1393400 12054188 12683688 353949 335382 1041929 924306 13567833 15336776 4000 5000 0 0 5929151 6265989 0 0 0 7574865 9396749 13508016 15667738 59817 -330962 19742889 18736014 14271239 12989705 5471650 5746309 X TO DEVELOP SCIENTIFICALLY SOUND, PRACTICAL TECHNICAL INFORMATION AND RESOURCES TO ADVANCE SCIENCE AND REGULATION FOR THE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY THROUGH THE EXPERTISE OF OUR GLOBAL MEMBERSHIP. 0 0 PROGRAMS & MEETINGS-EDUCATE MEMBERS AND NON-MEMBERS BY TEACHING DEVELOPMENTS IN MANUFACTURING AND QUALITY CONTROL FOR PRIMARY STERILE PRODUCT DEVELOPMENTS. TRAINING & RESEARCH INSTITUE (TRI)EDUCATIONAL COURSES - TECHNICAL TRAINING FOR SCIENTISTS IN THE PHARMACEUTICAL AREAS OF MANUFACTURING, DEVELOPMENT AND QUALITY CONTROL. TRAINING - TRAIN MEMBERS AND NON-MEMBERS TO BASIC MANUFACTURING TECHNIQUES CENTERED AROUND GMP GUIDELINES. MEMBERSHIP & CHAPTER SERVICES-PROVIDE THE LATEST GUIDELINES FOCUSING ON TECHNOLOGY INFORMATION ON MANUFACTURING, TECHNICAL REPORTS, AND QUALITY CONTROL. PUBLICATION SALES- PROVIDE THE LATEST SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION.SALES, EXHIBIT & SPONSORSHIP, ADVERTISING- PROVIDE THE LATEST SCIENCE, TECHNOLOGY AND REGULATORY INFORMATION 0 1 0 1 0 0 0 0 0 1 0 0 1 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 1 81 0 57 1 1 1 0 0 0 1 1 0 0 0 X 17 17 0 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 MD X JENNIFER BELL CFO 3016565900 4350 EAST WEST HIGHWAY STE 600 BETHESDA MD 20814 ANIL SAWANT PHD CHAIR 1.00 1.00 X X 0 0 0 MELISSA SEYMOUR MBA CHAIR-ELLECT 1.00 1.00 X X 0 0 0 SUSAN SCHNIEPP IMMEDIATE PAST CHAIR 1.00 1.00 X X 0 0 0 EMMA RAMNARINE TREASURER 1.00 1.00 X X 0 0 0 BETTINE BOLTRES PHD SECRETARY 1.00 1.00 X X 0 0 0 LISA BENNETT DIRECTOR 1.00 1.00 X 0 0 0 CHRISTIANA CAMPA DIRECTOR 1.00 1.00 X 0 0 0 ANDREW CHANG DIRECTOR 1.00 1.00 X 0 0 0 CYLIA CHEN QOI DIRECTOR 1.00 1.00 X 0 0 0 MIRKO GABRIELE DIRECTOR 1.00 1.00 X 0 0 0 MARC GLOGOVSKY DIRECTOR 1.00 1.00 X 0 0 0 ANDREW HOPKINS DIRECTOR 1.00 1.00 X 0 0 0 STEPHAN KRAUSE PHD DIRECTOR 1.00 1.00 X 0 0 0 IVY LOUIS DIRECTOR 1.00 1.00 X 0 0 0 AMY MCDANIEL DIRECTOR 1.00 1.00 X 0 0 0 BRIGITTE REUTTER-HAERLE DIRECTOR 1.00 1.00 X 0 0 0 OSAMU SKIROKIZAWA DIRECTOR 1.00 1.00 X 0 0 0 GLENN WRIGHT CEO 37.50 0.00 X 426542 0 46970 JENNIFER BELL CFO 37.50 0.00 X 239928 0 53529 DAVID HALL VP EXHIBITS 37.50 0.00 X 243228 0 66092 DAVID TALMAGE VP EDUCATION 37.50 0.00 X 217711 0 72104 MOLLY O'NEILL VP PROGRAMS 37.50 0.00 X 216974 0 61179 WALTER MORRIS III SR DIRECTOR PUBLICATIONS 37.50 0.00 X 174796 0 35212 ALETHEA TAVARES CHIEF OF STAFF 37.50 0.00 X 162887 0 27694 JOSHUA EATON SR DIRECTOR SRA 37.50 0.00 X 161218 0 38848 MICHAEL PORTER SR DIRECTOR, EDUCATION 37.50 0.00 X 140141 0 16817 FARAMARZ KOLIVAND SR WEB DEVELOPER 37.50 0.00 X 143243 0 34298 2126668 0 452743 17 0 1 0 BREAKOUT AUDIO VISUAL LLC 13342 BENCHLEY RD SAN DIEGO CA 92130 AUDIO VISUAL SERVICES 636154 2040 DIGITAL LLC 11619 HITCHING POST LANE STE 200 NO BETHESDA MD 20852 MARKETING SERVICES 405795 RSM US LLP 331 WEST 3RD ST SUITE 200 DAVENPORT IA 52801 IT SERVICES 340985 MULTIMEDIA PHARMA SCIENCES LLC 2 CLARKE DR SUITE 100 CRANBURY NJ 08512 ADVERTISING 188810 4 1124620 268780 260780 1393400 MEETINGS, EXHIBITS, & CONFERENCES 541900 8300956 8300956 MEMBERSHIP DUES 900099 2318293 2318293 EDUCATION 541900 1940933 1940933 JOURNAL SUBSCRIPTION 900099 123506 123506 12683688 287309 287309 112876 112876 48073 0 48073 48073 48073 741323 188707 552616 552616 ADVERTISING 541800 218208 218208 MISCELLANEOUS INCOME 900099 23439 23439 CANCELLATION FEES 900099 9260 9260 7907 7907 258814 15336776 13236304 218208 488864 X 5000 1644257 3492804 223648 563032 342248 16545 61920 66503 3163840 785664 877271 123763 92873 582015 1110701 131907 489137 69738 EVENT EXPENSES 1739263 DUES AND SUBSCRIPTIONS 38731 INTERNATIONAL TAX 21752 SOFTWARE DEVELOPMENT 15240 9886 15667738 348716 280891 846963 518 346030 298655 160601 24200 24006 263512 309995 8609115 6776707 2097384 1832408 8487168 8872064 6092189 5333542 1284102 1575959 19742889 18736014 1971976 2248099 1666930 1749728 2399748 1632277 8232585 7359601 14271239 12989705 X 5471650 5746309 5471650 5746309 19742889 18736014 -330962 605621 0 X 0 1 X 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 4069788 3522353 547435 4539327 3254354 1284973 1832408 DUE TO/FROM AFFILIATES 1499409 DEPOSITS 76550 1575959 DUE TO CHAPTERS 151342 LEASE LIABILITY 7208259 7359601 16151797 605621 28600 634221 15517576 -180800 -180800 15336776 15877138 28600 180800 209400 15667738 0 15667738 PART XI, LINE 4B - OTHER ADJUSTMENTS: COST OF GOODS SOLD -188,707. BAD DEBT RECOVERIES 7,907. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF GOODS SOLD 188,707. BAD DEBT RECOVERIES -7,907. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES CONFERENCE PLANNING 386262 0 0 0 0 0 0 386262 0 386262 0 0 1 0 0 0 SCHEDULE F, PART IV, LINE 3: THE ORGANIZATION REIMBURSES ITS GERMAN AFFFILIATE FOR EXPENSES INCURRED DURING THE YEAR. X 1 1 X X X 0 0 0 GLENN WRIGHT CEO 366827 0 52500 0 7215 0 46000 0 970 0 473512 0 0 0 DAVID HALL VP EXHIBITS 209696 0 31012 0 2520 0 46000 0 20092 0 309320 0 0 0 JENNIFER BELL CFO 198603 0 38899 0 2426 0 46000 0 7529 0 293457 0 0 0 DAVID TALMAGE VP EDUCATION 188260 0 27944 0 1507 0 58267 0 13837 0 289815 0 0 0 MOLLY O'NEILL VP PROGRAMS 187702 0 27864 0 1408 0 47400 0 13779 0 278153 0 0 0 WALTER MORRIS III SR DIRECTOR PUBLICATIONS 152568 0 21468 0 760 0 27244 0 7968 0 210008 0 0 0 JOSHUA EATON SR DIRECTOR SRA 143529 0 17433 0 256 0 25140 0 13708 0 200066 0 0 0 ALETHEA TAVARES CHIEF OF STAFF 154000 0 8700 0 187 0 20295 0 7399 0 190581 0 0 0 FARAMARZ KOLIVAND SR WEB DEVELOPER 127956 0 15156 0 131 0 20485 0 13813 0 177541 0 0 0 MICHAEL PORTER SR DIRECTOR, EDUCATION 139641 0 500 0 0 0 16817 0 0 0 156958 0 0 0 PART I, LINE 1A: PDA PAYS 80% OF THE COST FOR USE OF A HEALTH CLUB (GYM) FOR ALL OF ITS EMPLOYEES. X LABORATORY SUPPLIES 17 260780 COMPARABLE SALES 0 0 1 0 PART I, COLUMN (B): THE NUMBER REPORTED IN PART I, COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE CONSISTS OF THE ELECTED OFFICERS, IMMEDIATE PAST CHAIRMAN, AND PRESIDENT. IT SHALL ACT ON BEHALF OF THE BOARD OF DIRECTORS IN THE OPERATION OF THE ASSOCIATION AND SHALL HAVE SUCH AUTHORITY AS MAY BE ESTABLISHED FROM TIME TO TIME BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 6 THE ASSOCIATION HAS INDIVIDUAL MEMBERS. THE ASSOCIATION DOES NOT HAVE ANY STOCKHOLDERS. FORM 990, PART VI, SECTION A, LINE 7A PDA'S GLOBAL MEMBERSHIP IS ELIGIBLE TO VOTE TO ELECT PDA'S BOARD OF DIRECTORS. THE PROCESS IS AS FOLLOWS: A NOMINATING COMMITTEE, CONSISTING OF THE CHAIRMAN, CHAIRMAN-ELECT, AND IMMEDIATE PAST CHAIRMAN, SUBMITS TO THE BOARD OF DIRECTORS A SLATE WITH (2) NOMINATED CANDIDATES FOR EACH OFFICER POSITION AND (2) NOMINATED CANDIDATES FOR EACH ELECTED DIRECTOR POSITION. THE BOARD OF DIRECTORS THEN VOTES TO SELECT 1 CANDIDATE FOR EACH OPEN OFFICER POSITION AND 2 FOR DIRECTORS TO SEND TO THE FULL MEMBERSHIP FOR VOTING. AN ELECTRONIC BALLOT CONTAINING THE NAMES OF ALL CANDIDATES FOR ELECTION, WITH PROVISION FOR A "WRITE-IN" CANDIDATE FOR EACH POSITION TO BE FILLED, IS THEN PROVIDED TO EACH ASSOCIATION MEMBER ENTITLED TO VOTE. FORM 990, PART VI, SECTION A, LINE 7B BYLAWS AMENDMENT PROCESS: EACH PROPOSED AMENDMENT OF PDA'S BYLAWS, APPROVED BY VOTE OF AT LEAST TWELVE (12) DIRECTORS, SHALL BE SUBMITTED WITH A BALLOT TO ALL PDA MEMBERS ENTITLED TO VOTE. A PROPOSED BYLAWS AMENDMENT SHALL BECOME EFFECTIVE UPON RECEIVING A TWO-THIRDS (2/3) "YES" VOTE OF THE MEMBER BALLOTS RECEIVED. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE PRESIDENT AND EXECUTIVE COMMITTEE MEMBERS. THE FORM 990, IN PDF FILE FORMAT, IS THEN PROVIDED TO THE FULL GOVERNING BODY (BOARD OF DIRECTORS) PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C FROM PDA'S CONFLICT OF INTEREST POLICY: 1. DUTY TO DISCLOSE IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF THE COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. 2. DETERMINING WHETHER A CONFLICT OF INTEREST EXISTS AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE GOVERNING BOARD OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. 3. PROCEDURES FOR ADDRESSING THE CONFLICT OF INTEREST A. AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE GOVERNING BOARD OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE SHALL LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. B. THE CHAIRPERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. C. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER PDA CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. D. IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN PDA'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION IT SHALL MAKE ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. 4. VIOLATIONS OF THE CONFLICT OF INTEREST POLICY A. IF THE GOVERNING BOARD OR COMMITTEE HAS REASONABLE CAUSE TO BELIEVE A MEMBER HAS FAILED TO DISCLOSE ACTUAL OR POSSIBLE CONFLICTS OF INTEREST, IT SHALL INFORM THE MEMBER OF THE BASIS FOR SUCH BELIEF AND AFFORD THE MEMBER AN OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. B. IF, AFTER HEARING THE MEMBER'S RESPONSE AND AFTER MAKING FURTHER INVESTIGATION AS WARRANTED BY THE CIRCUMSTANCES, THE GOVERNING BOARD OR COMMITTEE DETERMINES THE MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, IT SHALL TAKE APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. THE CONFLICT OF INTEREST POLICY DOES MENTION FAMILY AND BUSINESS RELATIONSHIPS AS SOURCES FOR POTENTIAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 THE ASSOCIATION USES THE FOLLOWING METHODS TO DETERMINE THE COMPENSATION OF THE PRESIDENT/CEO AND OTHER KEY EMPLOYEES: COMPENSATION COMMITTEES, COMPENSATION STUDY OR SURVEY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE. THESE METHODS ARE USED TO ENSURE COMPENSATION IN WITHIN FAIR MARKET VALUE RANGE FOR THE INDUSTRY. FORM 990, PART VI, SECTION C, LINE 19 ASSOCIATION BYLAWS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MAINTAINED AND AVAILABLE TO THE ASSOCIATION'S GOVERNING BODIES AND MEMBERS. FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G OPERATING LEASE EXPENSE 944,277. CONTRACT RESOURCE 2,219,563. FOUNDATION FOR PHARMACEUTICAL EDUCATION TRAINING AND RESEARCH 4350 EAST WEST HWY STE 200 BETHESDA MD 20814 522075244 SUPPORT EDUCATION, TRAINING AND RESEARCH IN THE PHARMACEUTICAL DC 501(C)(3) LINE 12B, II PARENTERAL DRUG ASSOCIATION INC 1 PDA EUROPE GEMEINNUTZIGE GMBH AM BORSIGTURM 60 BERLIN GM 13507 SHARES PDA MISSION AS STATED ON PAGE 1 OF THIS FORM 990 GM NONPROFIT GERMAN PARENTERAL DRUG ASSOCIATION INC 1 1 0 0 1 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 PDA EUROPE GEMEINNUTZIGE GMBH D 1215523 COST PDA EUROPE GEMEINNUTZIGE GMBH L 116452 COST PDA EUROPE GEMEINNUTZIGE GMBH Q 269810 COST